Medical Device News Magazine

IPFL Expands Prototyping & Production Printing Possibilities with New Multi-Material Polyjet Printer

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

IPFL, experts in plastic machining, fabrication and 3D printing, has begun running the latest J850 Polyjet 3D printer from Stratasys. The machine will support the company’s compilation of 3D printing technologies and expand on its current polyjet capabilities with the J850’s latest advancements.

The Stratasys J850 is the fastest printer within the J- series by the American-Israeli manufacturer, able to produce highly accurate prototypes and tooling from a range of materials. IPFL’s polyjet addition also features a new super high-speed mode, through which the printer can utilize seven materials at once to provide five times more design iterations. This technology has advanced IPFL’s customer service with reliably strong, flexible, and transparent offerings in complex 3D printed parts.

Polyjet’s printing process, involving the distribution of resin droplets that harden under ultraviolet light, is regarded as one of the most accurate additive manufacturing technologies. The J850 offers unprecedented horizontal build layers 14 microns thin on a sizeable build envelope (495x395x195mm). Furthermore, the printer welcomes a variety of new materials, such as VeroVivid rigid photopolymers,

VeroUltraClear glass-like polymers, and ABS-Like: temperature resistant polymer that is tough against shrinkage. Backed by Pantone validation, IPFL now provides these materials in over 600,000 color variations.

IPFL Director Adam Bloomfield, said: “With the Stratasys J850 polyjet, we can further enhance our quality of parts for customer prototyping and production requirements. IPFL offers smooth and accurate parts in a short space of time, and is always committed to servicing its dedicated sectors. Moving forward, the J850 is a significant addition to our production of medical devices and will enhance our suite of 3D printing capabilities.”

For over 50 years IPFL has continually provided quality plastic components for industrial, medical, transport, aero, consumer, defense, and security sectors. The company has utilized polyjet since 2003, producing high precision prototypes with complex geometry and intricate detail. Its materials are medically approved and soluble, leaving pristine parts that can mimic overmolded products. The J850 is set to reduce IPFL’s process downtime from material changeovers with new integrated material bays, and will reduce the need for multiple print processes thanks to the material variety on offer.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”